Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.088
▾0.00 (0.00%)
Last trade: 01/02, 11:33PM
Market cap
$58.88m
20 min delay
Investor Presentations
Principal Activity
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Address
6 Wallace Ave, Toorak VIC 3142, Australia
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.088
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia